-
1دورية أكاديميةTherapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model
المؤلفون: Sebastian Kruse, Marleen Büchler, Philipp Uhl, Max Sauter, Philipp Scherer, Tammy C.T. Lan, Samantha Zottnick, Alexandra Klevenz, Ruwen Yang, Frank Rösl, Walter Mier, Angelika B. Riemer
المصدر: OncoImmunology, Vol 8, Iss 1 (2019)
مصطلحات موضوعية: cancer immunotherapy, therapeutic vaccination, hla-humanized mouse model, human papillomavirus (hpv), a2.dr1, pap-a2, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2162-402X
-
2Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model
المؤلفون: Philipp Scherer, Marleen Büchler, Samantha Zottnick, Max Sauter, Walter Mier, Sebastian Kruse, Tammy C.T. Lan, Frank Rösl, Ruwen Yang, Angelika B. Riemer, Philipp Uhl, Alexandra Klevenz
المصدر: OncoImmunology, Vol 8, Iss 1 (2019)
مصطلحات موضوعية: 0301 basic medicine, lcsh:Immunologic diseases. Allergy, medicine.medical_treatment, Immunology, chemical and pharmacologic phenomena, Major histocompatibility complex, lcsh:RC254-282, Epitope, 03 medical and health sciences, 0302 clinical medicine, Cancer immunotherapy, Immunology and Allergy, Medicine, a2.dr1, human papillomavirus (hpv), Original Research, hla-humanized mouse model, Ideal (set theory), cancer immunotherapy, biology, business.industry, therapeutic vaccination, virus diseases, Treatment options, pap-a2, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, female genital diseases and pregnancy complications, Vaccination, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, biology.protein, business, lcsh:RC581-607
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
المؤلفون: Kruse S; Immunotherapy & Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Büchler M; Immunotherapy & Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Uhl P; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany., Sauter M; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany., Scherer P; Immunotherapy & Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lan TCT; Immunotherapy & Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zottnick S; Immunotherapy & Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Klevenz A; Immunotherapy & Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg, Germany., Yang R; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rösl F; Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mier W; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany., Riemer AB; Immunotherapy & Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Vaccine Design, German Center for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany.
المصدر: Oncoimmunology [Oncoimmunology] 2018 Oct 29; Vol. 8 (1), pp. e1524694. Date of Electronic Publication: 2018 Oct 29 (Print Publication: 2019).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE